Jack O'Sullivan (@drjackosullivan) 's Twitter Profile
Jack O'Sullivan

@drjackosullivan

MD, PhD (MBBS, DPhil) | Cardiology 🫀 + Genetics 🧬 @Stanford | Aussie 🇦🇺

ID: 373149717

linkhttps://ashleylab.stanford.edu/about-us/postdoctoral-fellows-and-visiting-scholars calendar_today14-09-2011 02:31:34

1,1K Tweet

1,1K Followers

1,1K Following

Alan Karthikesalingam (@alan_karthi) 's Twitter Profile Photo

❤️Happy to share our new work “"Towards Democratization of Subspecialty Medical Expertise” arxiv.org/abs/2410.03741 Rare heart diseases exemplify a major global challenge: lifesaving access to subspecialist expertise for millions with complex conditions. We think AI might help.

❤️Happy to share our new work “"Towards Democratization of Subspecialty Medical Expertise” arxiv.org/abs/2410.03741

Rare heart diseases exemplify a major global challenge: lifesaving access to subspecialist expertise for millions with complex conditions. We think AI might help.
euan ashley (@euanashley) 's Twitter Profile Photo

One of the most promising areas for the application of AI in medicine is scaling specialty expertise. There simply aren't enough specialist doctors to care for everyone in need. We believe AI can help. As a first step towards that goal, we worked with the amazing Google medical

One of the most promising areas for the application of AI in medicine is scaling specialty expertise. There simply aren't enough specialist doctors to care for everyone in need. We believe AI can help.

As a first step towards that goal, we worked with the amazing Google medical
Derek Thompson (@dkthomp) 's Twitter Profile Photo

Fascinating paper (and post!) on AI in medicine - cardiologists working with AI said the machine's diagnosis, triage and management were equal or better than human cardiologists in most areas - the paper's summary comes with a generative AI podcast explaining the results

Jack O'Sullivan (@drjackosullivan) 's Twitter Profile Photo

Dr Carolyn Ho of Mass General Brigham kicking us off discussing small module therapy. From myosin modulation to SGLT2i in HCM, to the myosin *activation* with omecantiv in HFrEF and siRNA IN TTR amyloid with patisiran/vutrisiran and much more!

Dr Carolyn Ho of <a href="/MassGenBrigham/">Mass General Brigham</a> kicking us off discussing small module therapy. From myosin modulation to SGLT2i in HCM, to the myosin *activation* with omecantiv in HFrEF and siRNA IN TTR amyloid with patisiran/vutrisiran and much more!
Jack O'Sullivan (@drjackosullivan) 's Twitter Profile Photo

Great talk from N Bouatia-Naji, PhD on GWAS for drug discovery. She outlines steps to go from GWAS hit to drug target: 1. Integration with Omics 2. Mendelian Randomization #AHA2024 #AHA24

Great talk from <a href="/n_bouatianaji/">N Bouatia-Naji, PhD</a>  on GWAS for drug discovery. 

She outlines steps to go from GWAS hit to drug target: 
1. Integration with Omics 

2. Mendelian Randomization

#AHA2024 #AHA24
Jack O'Sullivan (@drjackosullivan) 's Twitter Profile Photo

Please join me and the entire SCICD team at the fantastic My Heart Counts Race. I have a team - join me 🏃🏃‍♂️🏃‍♀️💨 Team: classy.org/team/633506